Halozyme Therapeutics (HALO) Prepaid Assets (2010 - 2026)

Halozyme Therapeutics (HALO) has 17 years of Prepaid Assets data on file, last reported at $121.9 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $121.9 million, up 21.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $121.9 million (up 21.6% YoY), and the FY2025 annual result was $118.2 million, down 1.14% from the prior year.
• Prepaid Assets improved to $121.9 million in Q1 2026 per HALO's latest filing, from $118.2 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $133.0 million in Q2 2025 and troughed at $37.0 million in Q1 2023.
• A 5-year average of $76.6 million and a median of $63.1 million in 2022 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2023 and 2024: Prepaid Assets plunged 41.32% in 2023, then jumped 145.92% in 2024.
• A 5-year view of Prepaid Assets shows it stood at $71.3 million in 2022, then sank by 31.84% to $48.6 million in 2023, then jumped by 145.92% to $119.5 million in 2024, then slipped by 1.14% to $118.2 million in 2025, then advanced by 3.12% to $121.9 million in 2026.
• Business Quant data shows HALO's Prepaid Assets at $121.9 million in Q1 2026, $118.2 million in Q4 2025, and $95.0 million in Q3 2025.